CLINICAL MANAGEMENT GUIDELINE

Coronavirus infection

ICD10: Oth coronavirus as the cause of diseases classd elswhr [B97.29]

Treatment: General approach for mild presentation

It is a viral respiratory tract infection. It affects the upper and lowers respiratory tracts. Commonly characterized by fever, especially in adults (83%-98%), non-productive cough (57%-82%), and dyspnea (18%- 55%). The disease is strongly related to past exposure to such cases.


Defining facts about this plan: 1- Certain agents have been described in observational studies or are being used anecdotally based on in vitro or extrapolated evidence. 2- It is important to be aware that there are no controlled data supporting the use of any of these agents, and their efficacy for COVID-19 is unknown.

Success criteria: 1- Improving symptoms 2- No fever 3- Normal labs

Treatments

Level 1 / 1
pharmacological
Acetaminophen
ROUTE
Oral
DOSE
500.000 mg
FREQUENCY
q6-8 hr PRN
pharmacological
remdesivir
ROUTE
IV
DOSE
200.000 mg
FREQUENCY
OD
pharmacological
Hydroxychloroquine
ROUTE
Oral
DOSE
400.000 mg
FREQUENCY
OD
prevention
Respiratory isolation
procedures
Informing
procedures
Isolation technique
procedures
Plasma/plasma substitute transfusion
consultation
Referral to infectious diseases service
consultation
Referral to respiratory physician

View complete treatment plan

Access complete guideline of Coronavirus disease 2019 (Adult) now,
with powerful features to assist you for making better clinical management decision

  • Duplicating mechanism of action of effect
  • Weight based dosing
  • Contraindication
  • Renal dosing
  • Interactions to drugs or diseases
  • Hepatic dosing

And more...